Erratum: Discovery of (2 R)-2-(3-{3-[(4-methoxyphenyl)carbonyl]-2-methyl-6- (trifluoromethoxy)-1 H -indol-1-yl}phenoxy)butanoic acid (MK-0533): A novel selective peroxisome proliferator-activated receptor γ modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume

  • John J. Acton
  • , Taro E. Akiyama
  • , Ching H. Chang
  • , Lawrence Colwell
  • , Sheryl Debenham
  • , Thomas Doebber
  • , Monica Einstein
  • , Kun Liu
  • , Margaret E. McCann
  • , David E. Moller
  • , Eric S. Muise
  • , Yejun Tan
  • , John R. Thompson
  • , Kenny K. Wong
  • , Margaret Wu
  • , Libo Xu
  • , Peter T. Meinke
  • , Joel P. Berger
  • , Harold B. Wood

Research output: Contribution to journalComment/debate

4 Scopus citations
Original languageEnglish
Pages (from-to)9368
Number of pages1
JournalJournal of Medicinal Chemistry
Volume56
Issue number22
DOIs
StatePublished - 27 Nov 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this